180 related articles for article (PubMed ID: 33087055)
1. Selenium supplementation in patients with peripartum cardiomyopathy: a proof-of-concept trial.
Karaye KM; Sa'idu H; Balarabe SA; Ishaq NA; Sanni B; Abubakar H; Mohammed BL; Abdulsalam T; Tukur J; Mohammed IY
BMC Cardiovasc Disord; 2020 Oct; 20(1):457. PubMed ID: 33087055
[TBL] [Abstract][Full Text] [Related]
2. Clinical Features and Outcomes of Peripartum Cardiomyopathy in Nigeria.
Karaye KM; Sa'idu H; Balarabe SA; Ishaq NA; Adamu UG; Mohammed IY; Oboirien I; Umuerri EM; Mankwe AC; Shidali VY; Njoku P; Dodiyi-Manuel S; Olunuga T; Josephs V; Mbakwem AC; Okolie H; Talle MA; Isa MS; Ogah OS; Stewart S;
J Am Coll Cardiol; 2020 Nov; 76(20):2352-2364. PubMed ID: 33183509
[TBL] [Abstract][Full Text] [Related]
3. Temporal Trends in Clinical Characteristics and Outcomes for Peripartum Cardiomyopathy: The Nationwide Multicenter Registry Over 20 Years.
Bak M; Youn JC; Bae DH; Lee JH; Lee S; Cho DH; Choi JO;
J Am Heart Assoc; 2024 Jul; 13(13):e034055. PubMed ID: 38904229
[TBL] [Abstract][Full Text] [Related]
4. Impact of autoantibodies against the M2-muscarinic acetylcholine receptor on clinical outcomes in peripartum cardiomyopathy patients with standard treatment.
Ma G; Chen L; Yue Y; Liu X; Wang Y; Shi C; Song F; Shi W; Lo Y; Zhang L
BMC Cardiovasc Disord; 2021 Dec; 21(1):619. PubMed ID: 34963460
[TBL] [Abstract][Full Text] [Related]
5. Electrocardiographic findings in peripartum cardiomyopathy.
Honigberg MC; Elkayam U; Rajagopalan N; Modi K; Briller JE; Drazner MH; Wells GL; McNamara DM; Givertz MM;
Clin Cardiol; 2019 May; 42(5):524-529. PubMed ID: 30843220
[TBL] [Abstract][Full Text] [Related]
6. Review of Randomized Controlled Trials in Patients with Peripartum Cardiomyopathy.
Mujkanovic J; Qayyum AA
Curr Cardiol Rev; 2023; 19(2):e230822207933. PubMed ID: 36017853
[TBL] [Abstract][Full Text] [Related]
7. Anticoagulation Therapy in Specific Cardiomyopathies: Isolated Left Ventricular Noncompaction and Peripartum Cardiomyopathy.
Kido K; Guglin M
J Cardiovasc Pharmacol Ther; 2019 Jan; 24(1):31-36. PubMed ID: 29911432
[TBL] [Abstract][Full Text] [Related]
8. Rationale and design of a randomized, controlled multicentre clinical trial to evaluate the effect of bromocriptine on left ventricular function in women with peripartum cardiomyopathy.
Haghikia A; Podewski E; Berliner D; Sonnenschein K; Fischer D; Angermann CE; Böhm M; Röntgen P; Bauersachs J; Hilfiker-Kleiner D
Clin Res Cardiol; 2015 Nov; 104(11):911-7. PubMed ID: 26026286
[TBL] [Abstract][Full Text] [Related]
9. Recovery of left ventricular systolic function in peripartum cardiomyopathy: an observational study from rural Tanzania.
Katende A; Roos L; Urio VZ; Mahundi E; Myovela V; Mnzava D; Mlula C; Chitimbwa C; Raphael DM; Gingo W; Franzeck FC; Paris DH; Elzi L; Weisser M; Rohacek M
BMC Cardiovasc Disord; 2024 May; 24(1):243. PubMed ID: 38724901
[TBL] [Abstract][Full Text] [Related]
10. A novel score to predict left ventricular recovery in peripartum cardiomyopathy derived from the ESC EORP Peripartum Cardiomyopathy Registry.
Jackson AM; Goland S; Farhan HA; Yaseen IF; Prameswari HS; Böhm M; Jhund PS; Maggioni AP; van der Meer P; Sliwa K; Bauersachs J; Petrie MC
Eur Heart J; 2024 Apr; 45(16):1430-1439. PubMed ID: 38282532
[TBL] [Abstract][Full Text] [Related]
11. The effect of bromocriptine on left ventricular functional recovery in peripartum cardiomyopathy: insights from the BRO-HF retrospective cohort study.
Tremblay-Gravel M; Marquis-Gravel G; Avram R; Desplantie O; Ducharme A; Bibas L; Pacheco C; Couture E; Simard F; Poulin A; Malhamé I; Tran D; Rey E; Tournoux F; Harvey L; Sénéchal M; Bélisle P; Descarries L; Farand P; Pranno N; Diaz A; Afilalo J; Ly HQ; Fortier A; Jolicoeur EM;
ESC Heart Fail; 2019 Feb; 6(1):27-36. PubMed ID: 30565890
[TBL] [Abstract][Full Text] [Related]
12. Screening for peripartum cardiomyopathies using artificial intelligence in Nigeria (SPEC-AI Nigeria): Clinical trial rationale and design.
Adedinsewo DA; Morales-Lara AC; Dugan J; Garzon-Siatoya WT; Yao X; Johnson PW; Douglass EJ; Attia ZI; Phillips SD; Yamani MH; Tobah YB; Rose CH; Sharpe EE; Lopez-Jimenez F; Friedman PA; Noseworthy PA; Carter RE
Am Heart J; 2023 Jul; 261():64-74. PubMed ID: 36966922
[TBL] [Abstract][Full Text] [Related]
13. Bromocriptine for the treatment of peripartum cardiomyopathy: a multicentre randomized study.
Hilfiker-Kleiner D; Haghikia A; Berliner D; Vogel-Claussen J; Schwab J; Franke A; Schwarzkopf M; Ehlermann P; Pfister R; Michels G; Westenfeld R; Stangl V; Kindermann I; Kühl U; Angermann CE; Schlitt A; Fischer D; Podewski E; Böhm M; Sliwa K; Bauersachs J
Eur Heart J; 2017 Sep; 38(35):2671-2679. PubMed ID: 28934837
[TBL] [Abstract][Full Text] [Related]
14. Acute kidney injury predicts poor left ventricular function for patients with peripartum cardiomyopathy.
Zhu J; Liu W
BMC Cardiovasc Disord; 2021 Apr; 21(1):205. PubMed ID: 33888084
[TBL] [Abstract][Full Text] [Related]
15. Maternal and fetal prognosis of subsequent pregnancy in black African women with peripartum cardiomyopathy.
Yaméogo NV; Samadoulougou AK; Kagambèga LJ; Kologo KJ; Millogo GRC; Thiam A; Guenancia C; Zansonré P
BMC Cardiovasc Disord; 2018 Jun; 18(1):119. PubMed ID: 29914408
[TBL] [Abstract][Full Text] [Related]
16. Importance of Early Diagnosis in Peripartum Cardiomyopathy.
Lewey J; Levine LD; Elovitz MA; Irizarry OC; Arany Z
Hypertension; 2020 Jan; 75(1):91-97. PubMed ID: 31707840
[TBL] [Abstract][Full Text] [Related]
17. Influence of systolic blood pressure on outcomes in Nigerians with peripartum cardiomyopathy.
Sa'idu H; Balarabe SA; Ishaq NA; Adamu UG; Mohammed IY; Oboirien I; Umuerri EM; Mankwe AC; Shidali VY; Njoku P; Dodiyi-Manuel S; Olunuga T; Josephs V; Mbakwem AC; Okolie H; Talle MA; Isa MS; Adebayo RA; Tukur J; Isezuo SA; Umar H; Shehu MN; Ogah OS; Karaye KM
Niger J Clin Pract; 2022 Dec; 25(12):1963-1968. PubMed ID: 36537451
[TBL] [Abstract][Full Text] [Related]
18. Disparities in clinical features and outcomes of peripartum cardiomyopathy in high versus low prevalent regions in Nigeria.
Karaye KM; Ishaq NA; Sai'du H; Balarabe SA; Ahmed BG; Adamu UG; Mohammed IY; Oboirien I; Umuerri EM; Mankwe AC; Shidali VY; Dodiyi-Manuel S; Njoku P; Olunuga T; Josephs V; Mbakwem AC; Ogah OS; Tukur J; Okeahialam B; Stewart S; Henein M; Sliwa K;
ESC Heart Fail; 2021 Aug; 8(4):3257-3267. PubMed ID: 34137499
[TBL] [Abstract][Full Text] [Related]
19. Peripartum cardiomyopathy: A systematic review of the literature.
Asad ZUA; Maiwand M; Farah F; Dasari TW
Clin Cardiol; 2018 May; 41(5):693-697. PubMed ID: 29749620
[TBL] [Abstract][Full Text] [Related]
20. Initial Right Ventricular Dysfunction Severity Identifies Severe Peripartum Cardiomyopathy Phenotype With Worse Early and Overall Outcomes: A 24-Year Cohort Study.
Peters A; Caroline M; Zhao H; Baldwin MR; Forfia PR; Tsai EJ
J Am Heart Assoc; 2018 Apr; 7(9):. PubMed ID: 29686029
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
